Acute disseminated encephalomyelitis with severe neurological outcomes following virosomal seasonal influenza vaccine
Open Access
- 1 May 2014
- journal article
- case report
- Published by Taylor & Francis Ltd in Human Vaccines & Immunotherapeutics
- Vol. 10 (7), 1969-1973
- https://doi.org/10.4161/hv.28961
Abstract
Acute disseminated encephalomyelitis (ADEM) is an inflammatory, usually monophasic, immune mediate, demyelinating disease of the central nervous system which involves the white matter. ADEM is more frequent in children and usually occurs after viral infections, but may follow vaccinations, bacterial infections, or may occur without previous events. Only 5% of cases of ADEM are preceded by vaccination within one month prior to symptoms onset.Keywords
This publication has 18 references indexed in Scilit:
- Autoimmune disorders after immunisation with Influenza A/H1N1 vaccines with and without adjuvant: EudraVigilance data and literature reviewVaccine, 2012
- Acute Disseminated EncephalomyelitisJournal of Child Neurology, 2012
- Treatment of Acute Disseminated EncephalomyelitisCurrent Treatment Options in Neurology, 2012
- Causality assessment of serious neurologic adverse events following 2009 H1N1 vaccinationVaccine, 2011
- Eleven years of Inflexal® V—a virosomal adjuvanted influenza vaccineVaccine, 2009
- Encephalitis, myelitis, and acute disseminated encephalomyelitis (ADEM): Case definitions and guidelines for collection, analysis, and presentation of immunization safety dataVaccine, 2007
- Vaccine adverse events reported in post-marketing study of the Kitasato Institute from 1994 to 2004Vaccine, 2007
- Antibody response to influenza vaccination in the elderly: A quantitative reviewVaccine, 2006
- Influenza vaccines.2005
- Monitoring signals for vaccine safety: the assessment of individual adverse event reports by an expert advisory committee. Advisory Committee on Causality Assessment.2000